Functional and structural analyses of amino acid sequence variation in PDC β-lactamase reveal different mechanistic pathways toward cefiderocol resistance in Pseudomonas aeruginosa
Authors:
- Lucía González-PintoLGLucía González-Pinto
- María Antonia Gomis-FontMGMaría Antonia Gomis-Font
- Emilio LenceELEmilio Lence
- Michelle Outeda-GarcíaMOMichelle Outeda-García
- Tania Blanco-MartínTBTania Blanco-Martín
- Salud Rodríguez-PallaresSRSalud Rodríguez-Pallares
- Lucía Sánchez-PeñaLSLucía Sánchez-Peña
- Isaac Alonso-GarcíaIAIsaac Alonso-García
- Juan Carlos Vázquez-UchaJuan Carlos Vázquez-Ucha
- Alejandro BeceiroABAlejandro Beceiro
- Germán BouGBGermán Bou
- Concepción González-BelloConcepción González-Bello
Open Access
- 27 May 2025
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (7) , e0029225
Abstract
A wide variety of clinically observed amino acid alterations in the Pseudomonas aeruginosa chromosomal β-lactamase AmpC ( Pseudomonas -derived cephalosporinase [PDC]) are associated with increased resistance to cefepime, ceftolozane/tazobactam, or ceftazidime/avibactam, but their impact on cefiderocol resistance is unclear. We took advantage of a previously engineered collection of wild-type (PAO1) and iron uptake-deficient (PAO Δ piuC ) P. aeruginosa isolates producing 19 distinct PDC variants with substitutions in key catalytic regions. While most variants had moderate effects on cefiderocol minimum inhibitory concentrations compared to PDC-1, the E219K (Ω-loop) and L293P (helix H10) variants significantly affected cefiderocol activity. Kinetic studies revealed that both mutations improve cefiderocol hydrolysis through different enzymatic mechanisms compared to PDC-1 ( K m = 85.29 µM, k cat = 0.0036 s −1 , and k cat / K m = 0.00004 µM −1 s −1 ), leading to enhanced turnover in PDC E219K ( K m = 465.64 µM, k cat = 0.45 s −1 , and k cat / K m = 0.00096 µM −1 s −1 ) and improved affinity in PDC L293P ( K m = 2.69 µM, k cat = 0.0036 s −1 , and k cat / K m = 0.00135 µM −1 s −1 ). These mechanisms are also involved in resistance to ceftolozane and cefepime, identified as the preferred substrates for the E219K and L293P variants, respectively. Molecular dynamics (MD) simulation studies revealed that (i) rigidification of the Ω-loop in PDC E219K promotes optimal accommodation of the R 1 group of cefiderocol, enhancing nucleophilic attack by the catalytic serine; (ii) the less folded conformation of helix H10 in PDC L293P improves cefiderocol accommodation in the active site by establishing stronger hydrogen-bonding interactions with the R 2 group. Our findings demonstrate that the PDC β-lactamase may take advantage of the structural similarities between cefiderocol and other cephalosporins and accelerate hydrolysis by accommodating the E219K or L293P amino acid replacements.Keywords
This publication has 42 references indexed in Scilit:
- UCSF ChimeraX : Tools for structure building and analysisProtein Science, 2023
- AmberToolsJournal of Chemical Information and Modeling, 2023
- Cefiderocol activity is compromised by acquired extended-spectrum oxacillinases in Pseudomonas aeruginosaInternational Journal of Antimicrobial Agents, 2023
- Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort studyThe Lancet Microbe, 2023
- Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysisClinical Microbiology and Infection, 2021
- 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam AntibioticsJournal of Medicinal Chemistry, 2021
- Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to CefepimeClinical Infectious Diseases, 2020
- Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore CephalosporinClinical Infectious Diseases, 2019
- Structures of Ceftazidime and Its Transition-State Analogue in Complex with AmpC β-Lactamase: Implications for Resistance Mutations and Inhibitor Design,Biochemistry, 2001
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997